Recruiting

Phytonutrients

Sponsor:

Epiceutical Labs

Code:

NCT05349032

Conditions

Inflammation

Eligibility Criteria

Sex: Male

Age: 21 - 49

Healthy Volunteers: Accepted

Interventions

Curcumin

Study Details

Brief summary:

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. The study will secondarily look at inflammatory markers in the urine to determine any change.

Conditions

Inflammation

Study ID

NCT05349032

Start date

Mar 1, 2022

Status verified date

Apr, 2022

Completion date

Jun, 2022

Anticipated

Primary completion date

Apr 30, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 21 - 49

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Age and gender

Exclusion Criteria:

  • Cannot take any phytonutrient or curcumin supplement five days prior to commencement.

Study Design

Enrollment

15 participants

Anticipated

Allocation

Non randomized

Intervention Model

Crossover

Primary purpose

Basic Science

Interventions and Outcome Measures

Arms

other: Meriva

120 mg of curcumin in Meriva.

other: Longvida

120 mg of curcumin Longvida.

other: NovaSol

120 mg of curcumin NovaSol

other: CurcElite

120 mg of curcumin CurcElite

other: UltaCur

120 mg of curcumin Ultracur

Interventions

Curcumin

Oral supplement

Primary outcome measure

  • Bioavailability [ Time Frame: 0, 1, 2, 4, and 12 hours ]

Central Contacts and Locations

Central contacts

David Roberts, MPH

810777687research@epiceuticallabs.com

Locations

David Roberts

Recruiting

Charlottesville, Virginia, United States, 22902

Contacts

David Roberts, MPH

434-981-8629droberts@brocelite.com

More Information

Sponsor

Epiceutical Labs

Last update posted

Apr 27, 2022

Last verified

Apr, 2022

Keywords

  • infalmmation
  • bioavailability

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Epiceutical Labs on 2022-04-27.